Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Background:

A wide variety of tumors affect the pleura, both primary and secondary. The most common are metastatic carcinomas, usually of pulmonary origin. They manifest as malignant pleural effusion or multifocal pleural lesions. The extrapulmonary source of metastasis is mentioned but occurs less frequently. Pleural primary tumors other than diffuse malignant mesothelioma are either uncommon or rare and have received less attention. The World Health Organization (WHO) classified primary tumors of the pleura into three broad histogenetic classes of neoplasms, namely mesothelial tumors, mesenchymal tumors, and lymphoproliferative disorders.

Case Report:

A 41-year-old male patient was referred to our facility from the prevention medicine department with consolidation in the right lower zone of the chest, diagnosed as a case of encysted pleural effusion to rule out TB. This was discovered during a routine health examination for residency visa renewal. After laps and imaging workup, it was diagnosed as Solitary Fibrous Pleural Tumor (SFPT). The first surgical intervention was hampered by bleeding from the mass itself. Therefore, the patient underwent a second intervention after successful embolization of the arterial supply of the tumor by the interventional radiologist.

Conclusion:

Primary pleural neoplasms represent a small but significant group of heterogeneous tumors, many of which may mimic each other. Modern imaging modalities permit diagnosis and play a major role in staging and assessing surgical respectability. Novel molecular and immunohistochemical markers now allow confirmation of diagnosis and potentially form the basis for future targeted therapies. Embolization of tumor perfusion has a lifesaving role when needed.

© 2024 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882348882250303083436
2024-01-01
2025-10-31
Loading full text...

Full text loading...

/deliver/fulltext/nemj/5/1/NEMJ-5-E02506882348882.html?itemId=/content/journals/nemj/10.2174/0102506882348882250303083436&mimeType=html&fmt=ahah

References

  1. AttanoosR.L. PughM.R. The diagnosis of pleural tumors other than mesothelioma.Arch. Pathol. Lab. Med.2018142890291310.5858/arpa.2017‑0537‑RA30040453
    [Google Scholar]
  2. BondeA. SinghR. PrasadS.R. KamireddyD. AggarwalA. RamaniN. SabooS. ShanbhogueK. DasyamA.K. KatabathinaV.S. Mesotheliomas and benign mesothelial tumors: Update on pathologic and imaging findings.Radiographics.2023433e22012810.1148/rg.220128
    [Google Scholar]
  3. BosmanF.T.J.E. LakhaniS.R. OhgakiH. WHO Classification of Tumours.WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart.4th Ed TravisW.D. BrambillaE. BurkeA.P. MarxA. NicholsonA.G. Lyon, FranceIARC Publication20157422
    [Google Scholar]
  4. RobinsonL.A. Solitary fibrous tumor of the pleura.Cancer Contr.200613426426910.1177/10732748060130040317075563
    [Google Scholar]
  5. ZuoZ. ZhouH. SunY. MaoQ. ZhangY. Rapidly growing solitary fibrous tumors of the pleura: A case report and review of the literature.Ann. Transl. Med.202081489010.21037/atm‑20‑497432793734
    [Google Scholar]
  6. SavuC. MelinteA. PoseaR. GalieN. BalescuI. Pleural solitary fibrous tumors-a retrospective study on 45 patients.Medicina.202056418510.3390/medicina5604018532316178
    [Google Scholar]
  7. MercerR.M. WigstonC. BankaR. CardilloG. Management of solitary fibrous tumours of the pleura: A systematic review and meta-analysis.ERJ Open Res.20206300055202010.1183/23120541.00055‑202032832532
    [Google Scholar]
  8. CascioC.M.L. KaulV. DhooriaS. AgrawalA. Diagnosis of tuberculous pleural effusions: A review.Respirat. Medi.202118810660710.1016/j.rmed.2021.106607
    [Google Scholar]
  9. MalikJ. JavedN. NaeemH. SattarR.A. COVID-19 associated pneumonia and pleural effusion masquerading as heart failure in rheumatic heart disease.Eur. J. Case. Rep. Intern. Med.20207800184210.12890/2020_00184232789145
    [Google Scholar]
  10. WangP. MengZ. LiY. XuZ. Endometriosis-related pleural effusion: A case report and a PRISMA-compliant systematic review.Front Med.2021863104810.3389/fmed.2021.63104833859990
    [Google Scholar]
  11. KleinO. KeeD. MarkmanB. MichaelM. Immunotherapy of ipilimumab and nivolumab in patients with advanced neuroendocrine tumors: A subgroup analysis of the Ca209-538 clinical trial for rare cancers.Clin. Canc. Res.202026174454445910.1158/1078‑0432.CCR‑20‑062132532787
    [Google Scholar]
  12. ArnoldM. ParkJ.Y. CamargoM.C. LunetN. FormanD. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035.Gut.202069582382910.1136/gutjnl‑2019‑32023432001553
    [Google Scholar]
  13. SubbiahV. KreitmanR.J. WainbergZ.A. GazzahA. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: The phase 2 ROAR trial.Nat. Med.20232951103111210.1038/s41591‑023‑02321‑837059834
    [Google Scholar]
  14. BertoglioP. QuerzoliG. KestenholzP. ScarciM. Surgery for solitary fibrous tumors of the pleura: A review of the available evidence.Cancers.20231516416610.3390/cancers1516416637627194
    [Google Scholar]
  15. BoyrazB. HungY.P. Spindle cell tumors of the pleura and the peritoneum: Pathologic diagnosis and updates.APMIS.2022130314015410.1111/apm.1320334942046
    [Google Scholar]
  16. RerkpichaisuthV. HungY.P. Mesenchymal tumours of the pleura: Review and update.Histopathology202484116318210.1111/his.15035
    [Google Scholar]
  17. TariqM.U. DinN.U. Abdul-GhafarJ. ParkY.K. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.Diagn. Pathol.20211613210.1186/s13000‑021‑01095‑233879215
    [Google Scholar]
  18. KazazianK. DemiccoE.G. de PerrotM. Toward better understanding and management of solitary fibrous tumor.Surg. Oncol. Clin. N. Am.202231345948310.1016/j.soc.2022.03.00935715145
    [Google Scholar]
  19. SchöffskiP. TimmermansI. HompesD. StasM. Clinical presentation, natural history, and therapeutic approach in patients with solitary fibrous tumor: A retrospective analysis.Sarcoma.20202020138597810.1155/2020/138597832300277
    [Google Scholar]
  20. LucianoC. FrancescoA. GiovanniV. FedericaS. CesareF. CT signs, patterns and differential diagnosis of solitary fibrous tumors of the pleura.J. Thorac. Dis.201021212522263012
    [Google Scholar]
  21. MarchevskyA.M. KhoorA. WaltsA.E. NicholsonA.G. ZhangY.Z. RoggliV. CarneyJ. RodenA.C. TazelaarH.D. LarsenB.T. LeStangN. ChirieacL.R. KlebeS. TsaoM.S. De PerrotM. PierreA. HwangD.M. HungY.P. Mino-KenudsonM. TravisW. SauterJ. BeasleyM.B. Galateau-SalléF. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: Best current evidence from the literature and the international mesothelioma panel.Mod. Pathol.202033228129610.1038/s41379‑019‑0352‑331485011
    [Google Scholar]
  22. YeomY.K. KimM.Y. LeeH.J. KimS.S. Solitary fibrous tumors of the pleura of the thorax: CT and FDG PET characteristics in a tertiary referral center.Medicine (Baltimore)20159438e154810.1097/MD.000000000000154826402813
    [Google Scholar]
  23. DemiccoE.G. WagnerM.J. MakiR.G. GuptaV. IofinI. LazarA.J. WangW.L. Risk assessment in solitary fibrous tumors: Validation and refinement of a risk stratification model.Mod. Pathol.201730101433144210.1038/modpathol.2017.5428731041
    [Google Scholar]
  24. CardilloG. CarboneL. CarleoF. MasalaN. GrazianoP. BrayA. MartelliM. Solitary fibrous tumors of the pleura: An analysis of 110 patients treated in a single institution.Ann. Thorac. Surg.20098851632163710.1016/j.athoracsur.2009.07.02619853123
    [Google Scholar]
  25. Cruz-AlvarengaJ. LaínezC.F.B. SalgadoK.V.V. Undifferentiated pleomorphic sarcoma of the proximal thigh with neoplastic fever and metachronous sternal metastases: A case report and review of the literature.Cureus.20241610e7240110.7759/cureus.7240139588412
    [Google Scholar]
  26. FujiiS. HasegawaK. MaeharaT. KurppaK.J. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.Pathol. Res. Pract.202425415514810.1016/j.prp.2024.15514838277753
    [Google Scholar]
  27. ZhouJ. ZhuangZ. GaoR. LiR. ChenY. β-Glycosidase sensitive oral nanoparticles for combined photothermal and chemo treatment of colorectal cancer.J. Mater. Chem. B.20241261624163510.1039/D3TB02393A
    [Google Scholar]
  28. de BernardiA. DufresneA. MishellanyF. BlayJ.Y. Novel therapeutic options for solitary fibrous tumor: Antiangiogenic therapy and beyond.Cancers.2022144106410.3390/cancers1404106435205812
    [Google Scholar]
  29. AndrewsW.G. VallièresE. Implications of adverse biological factors and management of solitary fibrous tumors of the pleura.Thorac. Surg. Clin.202131334735510.1016/j.thorsurg.2021.04.00934304844
    [Google Scholar]
  30. MercerR.M. WigstonC. BankaR. CardilloG. BenamoreR. NicholsonA.G. Management of solitary fibrous tumors of the pleura: A systematic review and meta-analysis.ERJ Open Res.202063000550202010.1183/23120541.00055‑202032832532
    [Google Scholar]
/content/journals/nemj/10.2174/0102506882348882250303083436
Loading
/content/journals/nemj/10.2174/0102506882348882250303083436
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test